|
Synonyms: BMN 110 | rhGALNS | Vimizim®
elosulfase alfa is an approved drug (EMA & FDA (2014))
Compound class:
Peptide or derivative
|
Classification  |
|
| Compound class | Peptide or derivative |
| Approved drug? | Yes (EMA & FDA (2014)) |
| International Nonproprietary Names |
|
| INN number | INN |
| 9686 | elosulfase alfa |
| Synonyms |
| BMN 110 | rhGALNS | Vimizim® |
| Database Links |
|
| CAS Registry No. | 9025-60-9 (source: SciFinder) |
| GtoPdb PubChem SID | 178103964 |
| Search PubMed clinical trials | elosulfase alfa |
| Search PubMed titles | elosulfase alfa |
| Search PubMed titles/abstracts | elosulfase alfa |
| Wikipedia | Elosulfase_alfa |
